Background and Purpose: We earlier reported that risk factors for stroke prepare brain stem tissue for a modified Shwartzman reaction, including the development of ischemia and hemorrhage and the production of tumor necrosis factor-a, after a provocative dose of lipopolysaccharide. In the present study, we sought to determine whether blood and central nervous system cells of rats with the stroke risk factor of advanced age produce more proinflammatory and prothrombotic mediators than do those of young rats of the same strain.
Background and Purpose: We earlier reported that risk factors for stroke prepare brain stem tissue for a modified Shwartzman reaction, including the development of ischemia and hemorrhage and the production of tumor necrosis factor-a, after a provocative dose of lipopolysaccharide. In the present study, we sought to determine whether blood and central nervous system cells of rats with the stroke risk factor of advanced age produce more proinflammatory and prothrombotic mediators than do those of young rats of the same strain.
Methods: Levels of tumor necrosis factor-a and platelet activating factor in the cerebrospinal fluid and tumor necrosis factor-a in the serum of 2-year-old and 16-week-old Sprague-Dawley rats were monitored before and after challenge with lipopolysaccharide.
Results: No consistent tumor necrosis factor-a activity was found in the cerebrospinal fluid or blood of control animals. Intravenous administration of lipopolysaccharide (1.8 mg/kg) increased serum tumor necrosis factor-a levels but had no effect on tumor necrosis factor-a in the cerebrospinal fluid. Serum tumor necrosis factor-a increased much more in aged rats than in young rats. When lipopolysaccharide was injected intracerebroventricularly, tumor necrosis factor-a activity in cerebrospinal fluid increased significantly more in old rats than in young rats. Baseline levels of platelet activating factor in cerebrospinal fluid were significantly higher in old rats than in young rats, and the levels increased to a greater degree in aged rats on stimulation.
Conclusions: Rats with the stroke risk factor of advanced age respond to lipopolysaccharide with a more exuberant production of tumor necrosis factor-a and platelet activating factor than young rats of the same strain. These findings are consistent with our working hypothesis that perivascular cells are capable of exaggerated signaling of endothelium through cytokines such as tumor necrosis factor-a in animals with stroke risk factors. The effect of such signaling might be to prepare the endothelium of the local vascular segment for thrombosis or In parallel experiments, rats (four in each group) were anesthetized with halothane, and a sterile PE-50 catheter was implanted into the left femoral artery for continuous monitoring of blood pressure and sampling of arterial blood. The catheters were tunneled under the back skin, exited at the nape of the neck, and secured by a soft spring wire. After the rats had recovered from anesthesia, the arterial catheter was connected to a pressure transducer (Narco Bio-Systems RP 1500i, Houston, Tx.), and blood pressure and heart rate were continuously recorded on the Narcotrace 80 computerized physiograph (Narco) and sampled automatically every 30-60 seconds by a Northstar-Hazeltine computer for 30 minutes. Thereafter, a blood sample (1 mL) was withdrawn from the femoral artery for analysis of blood glucose. A single dose of lipopolysaccharide (1.8 mg/kg) was injected into the femoral arterial catheter, and the catheter was then reconnected to the pressure transducer and blood pressure monitored for an additional 3 hours. A second blood sample (1 mL) for blood glucose measurement was withdrawn 2 hours after lipopolysaccharide administration. The rats were then killed by injecting an overdose of pentobarbital into the femoral arterial catheter. Blood glucose was analyzed using routine methods.
Statistical Analysis
The dose-response relations were analyzed by twoway analysis of variance (ANOVA) using the css/pc statistical package for microcomputers (Complete Statistical System, StatSoft Inc., Tulsa, Okla. Results TNF-a activity in the CSF or serum of control animals was low or absent. The 1.8-and 3.6-mg/kg i.v. doses of lipopolysaccharide increased serum TNF-a levels in a dose-dependent manner, but the low dose of 1 ,tg/kg had no effect; the increase in serum TNF-a activity was greater in old rats than in young rats (Figure 1 declined to 12.8±9.4x 10' units/mL at 3 hours after lipopolysaccharide administration. In the old rats the corresponding values were 114.3 ±33.6x 103 units/mL and 33.3±16.4x 103 units/mL, respectively. The 3.6-mg/kg i.v. dose of lipopolysaccharide increased the CSF levels of TNF-a in the aged rats, whereas the lower doses had no effect (Figure 1, bottom panel) .
With the intracerebroventricular injection of lipopolysaccharide, TNF-a activity was increased in serum and CSF after the 1.35-and 3.0-mg per rat doses, whereas the low dose of 750 ng per rat had only minimal or no effect; at the highest dose the increase in serum TNF-a activity was significantly greater in old rats than in young rats (Figure 2, top panel) . After intracerebroventricular administration, the 1.35-and 3.0-mg per rat doses of lipopolysaccharide increased TNF-a activity in the CSF in a dose-dependent manner in the aged rats ( Figure 2, bottom panel) . The peak response in TNF-a activity in the CSF in the young rats was achieved at the 1.35-mg per rat dose. At both dose levels the increase in CSF TNF-a activity was greater in the aged than the young rats (Figure 2, bottom panel) .
The effect of lipopolysaccharide on the level of PAF in the CSF is summarized in level of PAF was higher in the old rats than in the young rats. Intravenously administered lipopolysaccharide had no effect on PAF release into CSF. With the intracerebroventricular injection of lipopolysaccharide, the CSF level of PAF increased significantly after the dose of 1.35 mg per rat in the old rats, whereas in the young rats the CSF PAF levels did not change significantly after either dose. In parallel studies, the white blood cell counts in untreated old and young rats ranged from 3x 103 to lOx 103 cells/gL. The mean white cell count in the old rats was 5.7±0.8x 103 and in the young rats 4.7±0.8x 103 cells/,uL. The percentages of neutrophils, lymphocytes, and monocytes in blood of old rats (n = 10) were 27+4% (mean±SEM), 64+4%, and 6+2%, respectively. The corresponding cell counts in the young rats (n=9) were 11±4%, 84±4%, and 3±1%, respectively. The total white blood cell counts or the monocyte counts were not significantly different in old rats compared with young rats. However, the old rats' blood contained significantly fewer lymphocytes (p<0.01, Student's two-tailed test for independent samples) and significantly more neutrophils (p<0.05, Student's two-tailed t test) than the blood of young rats.
The mean arterial pressure, heart rate, and serum glucose levels were measured in six rats. No significant differences were found in the hemodynamic variables or the serum glucose levels between the young and old rats. The mean arterial pressure and heart rate before administration of lipopolysaccharide were 104±4 mm Hg and 302± 28 beats per minute, respectively, in the 16-week-old rats. The corresponding values in the 2-year-old rats were 106±8 mm Hg and 323±29 beats per minute, respectively. At 2 hours after an intravenous bolus of 1.8 mg/kg lipopolysaccharide, the blood pressure and heart rate were 108±2 mm Hg and 319± 15 beats per minute in young rats and 103±2 mm Hg and 367±24 beats per minute in old rats. The nonfasting serum glucose in young rats was 299±20 mg/dL (mean+SEM, n=3) and in old rats was 313±35 mg/dL (n =3). Discussion Sprague-Dawley rats with the stroke risk factor of advanced age produced more TNF-a in blood and CSF in response to a provocative dose of lipopolysaccharide than did young rats. This species and strain and these ages were chosen to correspond to the susceptibilities to stroke as previously described.9 The definition of an 4"old" rodent differs among studies. Most of the studies examining the effect of aging on immune function have used 24-month-old animals as old test subjects. [17] [18] [19] [20] Some studies using 30-36-month-old mice as old subjects contend that the age of 24 months actually represents "middle age" in the rodent life span. [21] [22] [23] The effects of aging on cytokine-producing cells are complex. In agreement with our present data, serum TNF-a activity was increased more than 20-fold in 30-month-old mice compared with 6-month-old mice when the mice were treated with an intravenous injection of streptococcal endotoxin.24 The isolated murine peritoneal macrophages from 24-month-old mice produced more TNF-a when stimulated with lipopolysaccharide than did the macrophages from 8-month-old mice.2' Macrophages from Lewis rats older than 24 months had a slightly enhanced production of IL-1 compared with macrophages from 3-4-month-old rats.17 However, peritoneal macrophages from 36-month-old mice were not significantly different in their TNF-a production than 8-month-old mice of the same strain.21 Isolated peritoneal macrophages of 12-13-month-old (middle-aged) and 22-23-month-old (old) Fisher rats released less TNF-a than peritoneal macrophages of 2-3-month-old rats when challenged with Staphylococcus epidermidis. 18 Peritoneal macrophages of 24-month-old mice also produced less IL-1 than macrophages from 2-4-month-old mice.20 Earlier studies have suggested that any impairment in the capacity of macrophages to produce cytokines in vitro might be compensated for in vivo by the increased number of monocytes and macrophages in old animals.17 '19 In the present study, the monocyte counts in old rats (6+±2%) were not significantly different than in young rats (3+1%). Therefore, the increased TNF-a levels in the blood and CSF of old animals stimulated with lipopolysaccharide may indicate an increased capacity of cells from aged rats to produce TNF-a. The studies by Shimada24 demonstrating an increased in vivo production of TNF-a in the serum of old mice support this view. Furthermore, the in vivo data may not be directly comparable to in vitro studies that used isolated peritoneal macrophages because of functional differences determined by the tissue from which they were isolated and the method of isolation.25
Several B and T lymphocyte functions, such as the ability to produce antibodies in response to antigen stimulation, mitogen-induced proliferation, and cellmediated immune responses, also decrease with advancing age.17,222326 The impairment of cell-mediated immune reactivity associated with aging seems to be due mainly to a defect in the production of IL-2 by helper T cells, but the impaired capacity of macrophages to produce IL-1 in vitro and the reduced binding of cytokines by T cells could also serve as contributing factors. [18] [19] [20] [21] 26 It is important to note, however, that the phagocytic activity of monocytes and macrophages in aged mice and rats is normal.'927-31 The phagocytic function of blood monocytes in elderly persons is similar to that in young persons.32 Interestingly, phagocytic activity, lysosomal acid phosphatase activity, DNase cultured macrophages were significantly increased in 17-month-old mice compared with 2-6-month-old, or young, mice.33 The age-dependent increase in macrophage activity is particularly pronounced in New Zealand black mice, which exhibit progressively depressed cellular immunity.33 Interestingly, impaired T-cell function is also associated with hypertension, a known risk factor for stroke. 34 Moreover, the number of activated monocytes is significantly elevated in mature hypertensive rats compared with normotensive rats.'1135 Thus, it is possible that the decreased cellular immunity in aging and hypertension is compensated for by an increase in the number and activity of macrophages, as reported in athymic nude mice. 36 The exaggerated production of TNF-a in vivo has been demonstrated in spontaneously hypertensive rats.10"11 Expression of RNA message for monocyte chemoattractant protein-1 and immunoreactive TNF-a has also been detected in human atherosclerotic lesions.3-5 Our recent studies demonstrated increased expression of the intercellular adhesion molecule (ICAM)-1, increased accumulation of macrophages, and increased in vitro production of TNF-a by carotid arteries of hypertensive rats.37 Preliminary studies demonstrated enhanced in vitro production of TNF-a in carotid arteries obtained from aged Sprague-Dawley rats. The aged rats have also been reported to exhibit an increased reactivity to TNF-a or IL-1 in that the cytokine-induced increase in the plasma levels of plasminogen activator inhibitor activity in aged rats was greater than in young rats. 38 According to our working hypothesis, the relevance of the increased cytokine release to stroke lies in the ability of cytokines such as TNF-a to prepare vessels for ischemic and inflammatory tissue damage through increased adhesion of leukocytes and platelets on vascular endothelium and transformation of the endothelial surface from an actively anticoagulant to a procoagulant state. Some of the specific endothelial changes under the influence of TNF-a include the synthesis and surface expression of tissue factor,6 the synthesis and expression of PAF,6 the release of IL-1,6 the release of factor VIII,6 and the enhanced adhesion of monocytes and granulocytes6-8 through the expression of adhesion receptor molecules.6-8 In addition, TNF-a can inhibit anticoagulant mechanisms such as the thrombomodulin-protein C-protein S system and decrease fibrinolysis as the levels of plasminogen activator inhibitor are increased.6 The overall effect of these interactions is to render the endothelial cell surface procoagulant, increase the adhesion of platelets and leukocytes, and increase local permeability. Our working hypothesis thus suggests that an interaction between perivascular macrophages and endothelium through cytokines could contribute to an increased risk of stroke in advanced age. We believe that our findings could be potentially relevant to human stroke in that the altered state of blood vessels induced by stroke risk factors could render such vessels locally vulnerable to thrombosis or hemorrhage in response would develop as the focal consequence of disturbed regulation of systems mediating coagulation, inflammation, and immunity, which are normally required for preservation of the integrity of the organism. Increased risk for a thromboembolic stroke could be possible if this process were to take place mainly in the extracranial vessels supplying the brain, whereas changes occurring in the intraparenchymal microvessels could contribute to lacunar strokes. Although our present data seem to support the working hypothesis, it should be emphasized that the true relevance of our findings to human stroke can be assessed only in forthcoming clinical studies that examine the role of the cytokine system in stroke patients and individuals with stroke risk factors.
The levels of TNF-a in the CSF were greater after the intracerebroventricular injection of lipopolysaccharide than after its systemic administration, indicating a local production of TNF-a within the central nervous system. These findings agree with earlier studies, which showed that the TNF-a activity was greater in the CSF than in blood after the intracerebroventricular injection of lipopolysaccharide in hypertensive rats.'0"11 The perivascular macrophages derived from bone marrow39 could account for the production of TNF-a in the brain, because monocytes and macrophages are a major source for TNF-a.6"3 However, several other cell types in the central nervous system are capable of TNF-a expression. The ameboid microglia share many features with macrophages, including the production of IL-1 and TNF-a.40 Astrocytes may also be capable of transforming into macrophage-like cells41 and have been shown to release cytokines in vitro.40 Furthermore, macrophages within ependyma and meninges could also contribute to the TNF-a release into the CSF. In a previous study, we found that lipopolysaccharide induced a concentrationdependent TNF-a release in isolated rat brain slices. 37 The level of TNF-a reached 3,000+263 units/mg protein per hour after incubation with lipopolysaccharide (1 mg/mL). Because the meninges were routinely removed before slices were prepared for incubation, a predominant contribution by meningeal macrophages to the TNF-a release in the brain slices seems unlikely. In a recent study, TNF-a mRNA has been reported to be expressed in the normal mouse brain, but the effect of lipopolysaccharide was not tested. 42 This inference is supported by the recent finding of hemorrhagic necrosis of the neuropil after the administration of recombinant TNF-a into the central nervous system. 43 The present study also demonstrated an exaggerated release of an immediate proinflammatory mediator in the brains of aged animals, as evidenced by the increase of PAF in the CSF after the intracerebroventricular administration of provocative doses of lipopolysaccharide. PAF is a lipid mediator that induces platelet aggregation, increases vascular permeability, and acts as an endothelial adhesion receptor for white blood cells.12 PAF in the CSF could originate from multiple cell types, including the endothelial cells, monocytes and macrophages, neutrophils, glial cells, and neurons. [44] [45] [46] However, the mononuclear cells have been proposed as the primary source for PAF in responses to lipopolysaccharide.'3 Interestingly, TNF-a can induce PAF release from endothelial cultures.44 This finding may bear relevance to our results, because the high levels of PAF and TNF-a found in the CSF after lipopolysaccharide administration were temporally related.
In conclusion, the present study provides support for our working hypothesis that advanced age, a risk factor for stroke, creates a state of increased probability of an interaction between monocytes/macrophages and endothelial cells, thereby enhancing local thrombosis or hemorrhage through increased activity of cytokines. According to this hypothesis, risk factors for stroke are initially associated with a change in endothelium and a hyperactive state of the monocytes/macrophages. The endothelial change would probably involve the expression of endothelial adhesion receptors for monocytes, which in turn would facilitate the adherence of monocytes to the vessel wall and transendothelial migration in both large and small vessels, leading to local deposits of monocyte clusters in segments of the blood vessels. These monocyte clusters could then periodically signal the vessel endothelium through the release of prothrombotic, proinflammatory, and chemotactic mediators such as TNF-a, PAF, and, perhaps, IL-1 to convert the endothelium to a procoagulant state and, in effect, prepare those vessel segments in a manner similar to the localized Shwartzman paradigm. Complement activation or any stimulus leading to activation of the coagulation system (factors such as natural oscillation of coagulation potential, stress, infection, trauma, and inflammation) could then precipitate a localized reaction within this prepared vessel segment and lead to a local thrombosis or hemorrhage. Because we have chosen to test this hypothesis first in an animal model, the conclusions of this study at this point are restricted to the species used. However, many aspects of this work can be tested in humans, and it remains for these future studies to show whether the proposed mechanisms are operating in clinical stroke.
